Skip to main content
Equibles
FBIO logo

FBIO · Fortress Biotech, Inc. · Webcasts, Transcripts & Audio

Track FBIO — free

Use FBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.99 -0.02 (-1.00%) At close · Nov 12 Q3 2025 earnings call transcript
Rebalance outlook locked
Market Cap
$73.19M
Shares
36.78M
Volume · Nov 12 297.96K Avg daily vol (3M) 315.02K

Fortress Biotech, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Fortress Biotech, Inc. (FBIO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Fortress Biotech, Inc. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    


    
    

        

            
            
            
            
        

            

                
                    
                    
                    
            

        
        
    


    
    

            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q3

                    
2025-11-14

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                EMROSI Launch Performance
                                Market Access and Payer Coverage
                                Legacy Product Portfolio
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$17.63M

▲ 20.5% YoY                                

                                

                                    
Diluted EPS

                                    
$0.11

                                

                                

                                    
Gross margin

                                    
67.4%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q4

                    
2025-03-31

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$15.12M*

▼ 24.2% YoY                                

                                

                                    
Gross margin

                                    
69.1%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q2

                    
2024-08-13

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q2 2024 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$14.90M

▼ 14.3% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.73

                                

                                

                                    
Gross margin

                                    
61.6%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q4

                    
2023-03-30

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q4 2022 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$16.40M*

▼ 10.2% YoY                                

                                

                                    
Gross margin

                                    
53.0%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q3

                    
2022-11-14

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q3 2022 Earnings Call Transcript

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$16.53M

▼ 21.6% YoY                                

                                

                                    
Diluted EPS

                                    
$-4.11

                                

                                

                                    
Gross margin

                                    
56.3%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q2

                    
2022-08-11

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q2 2022 Earnings Call Transcript

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$18.89M

▲ 5.8% YoY                                

                                

                                    
Diluted EPS

                                    
$-3.90

                                

                                

                                    
Gross margin

                                    
59.6%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q1

                    
2022-05-12

                


                
                

                    
Fortress Biotech, Inc. (FBIO) Q1 2022 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$23.93M

▲ 106.5% YoY                                

                                

                                    
Diluted EPS

                                    
$-2.70

                                

                                

                                    
Gross margin

                                    
65.7%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
    

    

        
Showing 1–7 of 7 webcasts

    

    

    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1429260
                    
                    
                        CUSIP
                        34960Q307
                    
                    
                        13F (30d)
                        44 filings
                        31 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations